Page 198 - HIV/AIDS Guidelines
P. 198

Table 15a. Drug Interactions between Protease Inhibitors* and Other Drugs  (Page 10 of 11)



             Concomitant        PI       Effect on PI or Concomitant Drug   Dosing Recommendations and Clinical
                 Drug                            Concentrations                          Comments

                           RTV-boosted PIs

                           ATV/r, DRV/r,  ATV/r, DRV/r, FPV/r             Opioid withdrawal unlikely but may occur. No
                                                    d
                           FPV/r, LPV/r,  ↓ R-methadone AUC 16%−18%;      adjustment in methadone usually required but
                           SQV/r, TPV/r  LPV/r ↓ methadone AUC 26%–53%;   monitor for opioid withdrawal and increase methadone
                                        SQV/r 1000/100 mg BID             dose as clinically indicated.
                                                    d
                                        ↓ R-methadone AUC 19%;
                                                         d
                                        TPV/r ↓ R-methadone AUC 48%
             Methadone
                           PIs without RTV
                           ATV          No significant effect             No dosage adjustment necessary.
                           FPV          No data with unboosted FPV        Monitor and titrate methadone as clinically indicated.
                                                       d
                                        APV ↓ R-methadone C min  21%, AUC no  The interaction with FPV is presumed to be similar.
                                        significant change

             Phosphodiesterase Type 5 (PDE5) Inhibitors
                           All PIs      DRV/r + sildenafil 25 mg similar to sildenafil  For treatment of erectile dysfunction
                                        100 mg alone;                     Start with sildenafil 25 mg every 48 hours and
                                        RTV 500 mg BID ↑ sildenafil AUC 1000%;  monitor for adverse effects of sildenafil.
             Sildenafil
                                        SQV unboosted ↑ sildenafil AUC 210%
                                                                          For treatment of PAH
                                                                          Contraindicated
                           All PIs      RTV 200 mg BID ↑ tadalafil AUC 124%;  For treatment of erectile dysfunction
                                        TPV/r (1st dose) ↑ tadalafil AUC 133%;  Start with tadalafil 5-mg dose and do not exceed a
                                        TPV/r steady state: no significant effect    single dose of 10 mg every 72 hours. Monitor for
                                                                          adverse effects of tadalafil.
                                                                          For treatment of PAH
                                                                          In patients on a PI >7 days:
                                                                          Start with tadalafil 20 mg once daily and increase to
                                                                          40 mg once daily based on tolerability.
             Tadalafil
                                                                          In patients on tadalafil who require a PI:
                                                                          Stop tadalafil >24 hours prior to PI initiation, restart
                                                                          7 days after PI initiation at 20 mg once daily, and
                                                                          increase to 40 mg once daily based on tolerability.
                                                                          For treatment of benign prostatic hyperplasia
                                                                          Maximum recommended daily dose is 2.5 mg per
                                                                          day
             Vardenafil    All PIs      RTV 600 mg BID ↑ vardenafil AUC   Start with vardenafil 2.5 mg every 72 hours and
                                        49-fold                           monitor for adverse effects of vardenafil.















            Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents        K-28

                            Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
   193   194   195   196   197   198   199   200   201   202   203